• Gene fusion; HGNC; HGNC:2726; DDIT3 + HGNC; HGNC:4010; FUS; Name(s)=FUS-DDIT3, TLS-CHOP (PubMed=27270875).
  
• Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=27270875).
  

PubMed=16983332; DOI=10.1038/sj.onc.1209996
Candeias M.M., Powell D.J., Roubalova E., Apcher S., Bourougaa K., Vojtesek B., Bruzzoni-Giovanelli H., Fahraeus R.
Expression of p53 and p53/47 are controlled by alternative mechanisms of messenger RNA translation initiation.
Oncogene 25:6936-6947(2006)

PubMed=20515481; DOI=10.1186/1471-2407-10-249; PMCID=PMC2889895
Andersson M.K., Goransson M., Olofsson A., Andersson C., Aman P.
Nuclear expression of FLT1 and its ligand PGF in FUS-DDIT3 carrying myxoid liposarcomas suggests the existence of an intracrine signaling loop.
BMC Cancer 10:249.1-249.10(2010)

PubMed=24726063; DOI=10.1186/1756-9966-33-33; PMCID=PMC4022359
Koelsche C., Renner M., Hartmann W., Brandt R., Lehner B., Waldburger N., Alldinger I., Schmitt T., Egerer G., Penzel R., Wardelmann E., Schirmacher P., von Deimling A., Mechtersheimer G.
TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities.
J. Exp. Clin. Cancer Res. 33:33.1-33.8(2014)

PubMed=25393000; DOI=10.1371/journal.pone.0113110; PMCID=PMC4231113
Stahlberg A., Kabjorn-Gustafsson C., Engtrom K., Thomsen C., Dolatabadi S., Jonasson E., Li C.-Y., Ruff D., Chen S.-M., Aman P.
Normal and functional TP53 in genetically stable myxoid/round cell liposarcoma.
PLoS ONE 9:E113110-E113110(2014)

PubMed=27270875; DOI=10.1038/labinvest.2016.64; PMCID=PMC4965313
de Graaff M.A., Yu J.S.E., Beird H.C., Ingram D.R., Nguyen T., Liu J.J.-H., Bolshakov S.V., Szuhai K., Aman P., Torres K.E., Lev D.C., Nielsen T.O., Bovee J.V.M.G., Lazar A.J.F., Somaiah N.
Establishment and characterization of a new human myxoid liposarcoma cell line (DL-221) with the FUS-DDIT3 translocation.
Lab. Invest. 96:885-894(2016)